Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
04/2007
04/10/2007US7202219 Induces production of butyrate and stimulates the growth of beneficial bacteria in the human colon; useful in food or the like as preventive drug against colon cancer.
04/10/2007US7202214 Rhizoc3 antimicrobial polypeptides and their uses
04/10/2007US7202210 Premature peptide for use in treatment of nervous system, muscular, heart, diabetic and bone disorders
04/10/2007US7202086 Method for massive directed mutagenesis
04/10/2007US7202085 Acylated Homoserine Lactone (AHL) compounds and AHL receptors derived from bacterial quorum sensing systems; inducible or repressible promotors regulate gene expression in plants and plant cells
04/10/2007US7202083 capable of efficiently expressing a gene of interest in plants
04/10/2007US7202077 Comprises nucleotide sequences for use as gene transfer tools; plasmids; expression vectors
04/10/2007US7202072 Genetically engineered eukaryotic hydrolase expressed in methylotrophic yeast for identifying modulators of tumor activities
04/10/2007US7202071 Peptidyl t-RNA hydrolase (PTH)
04/10/2007US7202069 novel enzymes that can reduce 4-haloacetoacetic acid esters using NADH as a coenzyme and produce (S)-4-halo-3-hydroxybutyric acid esters having high optical purities
04/10/2007US7202067 Carotene synthase gene and uses therefor
04/10/2007US7202064 A polymer produced by providing substrates selected from hydaroxyalkonate monomers wherein the biological system expresses enzymes selected from polyhydroxyalkanoate synthase, acyl-coA transferase etc. such that polymers accumulate
04/10/2007US7202063 Processes for the production of rhamnolipids
04/10/2007US7202062 an improved process for isolation of (HMG)-CoA reductase inhibitors; comprises a step of reacting the isolated (HMG)-CoA reductase inhibitor with an organic or inorganic cation source to generate a salt form of the inhibitor
04/10/2007US7202061 fermentaion of amino acids for use in human medicine, foods and animal nutrients; fermenting modified coryneform bacterium; modifiied by reducing or eliminating the intracellular activity of MikE17 in said cell relative to the activity of MikE17 in an unmodified bacterium of the same strain
04/10/2007US7202060 Process for producing L-amino acids via fermentation method
04/10/2007US7202059 Fusion proteins capable of being secreted into a fermentation medium
04/10/2007US7202057 DNAs encoding rat histamine receptors of the H4 subtype
04/10/2007US7202056 Polynucleotides encoding a human cell surface protein with immunoglobulin folds, BGS-19
04/10/2007US7202055 Preparing cells for use as bioreactors for expression of heterologous polypeptides
04/10/2007US7202054 Comprises nucleotide sequences coding transport proteins for use as tool in biological pest control; insecticides
04/10/2007US7202053 Assay determining the activity of an agent to decrease cell division; contacting protein capable of superoxide production with compound of interest and and measuring the ability of the agent to decrease superoxide production, inhibit diaphorase activity or bind the protein
04/10/2007US7202052 Regulatory protein for use in induction of nicotinamide adenine dinucleotide oxidase (NOX) for use as free radical quencher in prevention and treatment of cardiovascular and cell proliferative disorders
04/10/2007US7202049 Mitogen-activated protein kinase p38-2 and methods of use therefor
04/10/2007US7202040 Method for screening compounds which change the binding properties of a protein with a ligand
04/10/2007US7202025 Control of gene expression
04/10/2007US7201923 Nutraceuticals, drugs, contains an active, sensitive encapsulant, such as a live microorganism or an enzyme dissolved or dispersed in a liquid plasticizer is admixed with a plasticizable matrix material; shelf-stable, controlled release, discrete, solid particles from a liquid encapsulant
04/10/2007US7201908 Modified HPV E6 and E7 genes and proteins useful for vaccination
04/10/2007US7201906 Method to prepare compositions comprising yeast treated with electromagnetic energy
04/10/2007US7201895 High-affinity antagonists of ELR-CXC chemokines
04/10/2007CA2361701C Microbial process for preparing pravastatin
04/10/2007CA2292706C Method for administering viable microorganism composition for poultry
04/10/2007CA2267647C Esterases, dna encoding therefor and vectors and host cells incorporating same
04/10/2007CA2214805C Process for biological control of calamagrostis canadensis using a low temperature basidiomycete
04/10/2007CA2084351C P0438 - a new calcium-regulated promoter
04/10/2007CA2071016C Method for detecting bovine diarrhoea virus infection nucleotide sequence encoding a protein induced by this virus infection and recombinant proteins and antigens relating thereto
04/05/2007WO2007038755A1 In vitro protein synthesis systems for membrane proteins that include apolipoproteins and phospholipid-apolipoprotein particles
04/05/2007WO2007038466A2 Treatment of bipolar disorder utilizing anti-fungal compositions
04/05/2007WO2007038420A2 Process for stabilization of bacterial cells
04/05/2007WO2007037770A1 Method for producing immobilised bacteria cells
04/05/2007WO2007037228A1 Anode for biological power generation and power generation method and device utilizing it
04/05/2007WO2007036795A1 Non-pressurised pre-treatment, enzymatic hydrolysis and fermentation of waste fractions
04/05/2007WO2007035998A1 Assessment of infectious bacteria
04/05/2007WO2007011670A3 Heterodimeric four helix bundle cytokines
04/05/2007WO2007003773A3 Use of a yeast extract in the form of an active agent for inducing a synthesis of sirt proteins in skin cells
04/05/2007WO2007001796A3 Method for sustained microbial production of hydrogen gas in a bioreactor utilizing an equalization tank
04/05/2007WO2006135711A3 System for sustained microbial production of hydrogen gas in a bioreactor
04/05/2007WO2006093824A3 Influenza virus harvester
04/05/2007WO2006091118A3 A NEW STRAIN OF PAENIBACILLUS CURDLANOLYTICUS, A METHOD OF MUTANASE PRODUCTION, THE APPLICATION OF α-L ,3-GLUCAN FOR THE PRODUCTION OF MUTANASE, AND AN ENZYMATIC PREPARATION
04/05/2007WO2005056762A3 Truncated cmv promoters and vectors containing same
04/05/2007US20070079394 for yeast; splicing
04/05/2007US20070079388 Human hookworm model and method for maintaining human hookworm in a non-human primate
04/05/2007US20070077655 Labels, containers, system and method for providing reagents
04/05/2007US20070077642 Steroid receptor modulation of gene expression
04/05/2007US20070077638 Microorganisms that extracellularly secrete lipids and methods of producing lipid and lipid vesicles encapsulating lipids using said microorganisms
04/05/2007US20070077637 Microorganisms that extracellularly secrete lipids and methods of producing lipid and lipid vesicles encapsulating lipids using said microorganisms
04/05/2007US20070077634 Microorganism
04/05/2007US20070077633 producing an amide from the corresponding nitrile by a microorganism capable of producing a nitrile hydratase biocatalyst ; the microorganism is stored as none actively growing free cells in a storage medium; fermentation
04/05/2007US20070077631 use in host cells for biosynthesis of fine chemicals such as lysine; gene stability, gene expression or protein secretion/protein folding (SES proteins)
04/05/2007US20070077625 Adding to the microbial fermentation broth or homogenate, a solution of 6,9-diamino-2-ethoxyacridine lactate (ethacridine lactate) to precipitate host cell impurities, polypeptide remains soluble, separating the desiered polypeptide
04/05/2007US20070077622 Expression vector comprising nucleotide sequences coding sugar metabolism and oxidative phosphorylation (SMP) proteins for enhancing production of functional heterologous polypeptides
04/05/2007US20070077621 Production of CPD glycosylases
04/05/2007US20070077620 Expressing nucleic acid that codes a gene with tRNASep activity and one that codes a gene with SepRS that preferentially aminoacylates tRNASep with phosphoserine; the tRNASep recognizes codons so that phosphoserine is incorporated; sequences of Archaeoglobus fulgidus, or of a methanogenic archaea
04/05/2007US20070077616 Biosynthesis of isopentenyl pyrophosphate
04/05/2007US20070077592 Hemipteran glutamate decarboxylase
04/05/2007US20070077576 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins
04/05/2007US20070077569 Transgenic cell which produces sucrose isomerases for use in generation of isomaltulose from sucrose; sugar substitute
04/05/2007US20070077251 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
04/05/2007US20070077244 Inhibitor protein of the wnt signal pathway
04/05/2007US20070077238 Production of organic and inorganic selenium compounds by lactic acid bacteria
04/05/2007US20070077227 Preparing DNA binding protein comprising multiple zinc finger domains for use in identifying modulators of protein-nucleic acid recognition; gene expression inhibition
04/05/2007US20070077212 Protein with activity of hydrolyzing amylopectin, starch, glycogen and amylose, gene encoding the same, cell expressing the same, and production method thereof
04/05/2007DE10334811B4 Kälte-induzierbares Expressionssystem Cold-inducible expression system
04/05/2007CA2648786A1 Sustainable supply of bioactive marine products
04/05/2007CA2624187A1 Non-pressurised pre-treatment, enzymatic hydrolysis and fermentation of waste fractions
04/04/2007EP1770167A2 Regeneration
04/04/2007EP1770164A2 Streptococcus pneumoniae antigens and vaccines
04/04/2007EP1770163A2 Antagonists of interleukin-15
04/04/2007EP1770161A2 BMP-11 compositions
04/04/2007EP1770160A1 Monocyte-derived nucleic acids and related compositions and methods
04/04/2007EP1770159A1 Process for manufacturing a pharmaceutical composition for treating diabetes
04/04/2007EP1770100A2 Transferrin receptor genes of Moraxella
04/04/2007EP1769070A2 Polypeptides having alpha-glucosidase activity and polynucleotides encoding same
04/04/2007EP1769065A1 Vaccine composition against rhodococcus equi
04/04/2007EP1541673B1 Probiotics for pet food applications
04/04/2007EP1414858B1 Single chain camelid vhh antibodies, method for their production in a mammal, and their uses
04/04/2007EP1352056B1 Polypeptides capable of eliciting an immune reaction against cancer
04/04/2007EP1309707B1 Assays for alternative lengthening of telomeres in human cells
04/04/2007EP1298204B1 Novel inulin synthase and process for producing inulin by using the same
04/04/2007EP1276876B1 Expression-regulating sequences from filamentous fungus chrysosporium
04/04/2007EP1228197B1 Symbiotic bacteria and their uses
04/04/2007EP1171610B1 Nucleic acid sequences to proteins involved in isoprenoid synthesis
04/04/2007EP0985043B1 Lactic acid bacterial starter cultures and compositions thereof
04/04/2007EP0981631B1 Polypeptides having aminopeptidase activity and nucleic acids encoding same
04/04/2007EP0600865B2 Xylanase production
04/04/2007CN1942588A Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
04/04/2007CN1942585A Nucleic acid construct containing full-length genome of human hepatitis c virus, recombinant full-lenght virus genome replicative cell having the nucleic acid construct transferred thereinto and metho
04/04/2007CN1942579A Site-specific incorporation of redox active amino acids into proteins
04/04/2007CN1942575A Culturing double vessel and culturing method
04/04/2007CN1940073A Production of gene recombinant fused protein K1 VEGF121